ABEV vs MDLZ
Ambev S.A. and Mondelez International, both Consumer Defensive
Mondelez International is the larger company at $79B against $51B. Over the past year ABEV returned +43% against -0.5% for MDLZ. The RyuScore puts ABEV ahead, 85 against 62 out of 100.
| Figure | ABEV | MDLZ |
|---|---|---|
| Last close | $3.24 | $61.80 |
| Market cap | $51B | $79B |
| Trailing P/Elower is cheaper for the same earnings, not automatically better | n/a | 30.6 |
| Dividend yield | n/a | 3.1% |
| 1-year return | +43% | -0.5% |
| 5-year return | +34% | +16% |
| RyuScoresector-relative, 1–10 | 85/100 | 62/100 |
Figures from SEC filings and end-of-day closes. Highlighting marks the higher or lower number, which is not the same as the better investment, a low P/E can be a warning and a high one can be deserved.
Ambev S.A.
Mondelez International
Revenue of $10B in Q1 2026, net income $560M. Its largest reported line is Gum And Candy, 32% of the disclosed total.
Open these two in the interactive comparison to add more names, change the period or see the correlation.